Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this study is to understand whether a brief, three session program can be helpful in reducing symptoms related to both chronic pain and stressful experiences/trauma.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Brief Intervention | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Trauma Focused Emotional Awareness and Expression Therapy (EAET) | Behavioral | The intervention is three-session program which includes pain neuroscience education, education on the relationship between trauma and chronic pain, and skills training to reduce pain- and stress-related symptoms. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of Recruitment | Feasibility of recruitment: Rate of ≥70% of the patients who are identified as eligible for the study will agree to participate and enroll. | At screening |
| Treatment Completion | Rate of ≥70% of participants who start the intervention will complete at least 2 of the 3 sessions. | From enrollment to end of treatment at 4 weeks |
| Feasibility of Data Collection | Rate of ≥70% of participants will complete the survey at end of treatment and at 1-month follow-up. | At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment) |
| Treatment Credibility | Rate of ≥70% of participants will report average credibility and expectancy scores greater than the scale's midpoint. | At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment) |
| Treatment Helpfulness | Rate of ≥70% participants will report average treatment helpfulness scores greater than the scale's midpoint. | At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment) |
| Measure | Description | Time Frame |
|---|---|---|
| Pain Interference | Pain interference Sub-scale of the Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29). Range 4-20; higher scores indicate worse pain interference. | At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment) |
| Pain Catastrophizing |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Brigham and Women's Hospital | Chestnut Hill | Massachusetts | 02467 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D059350 | Chronic Pain |
| D014947 | Wounds and Injuries |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Pain Catastrophizing Scale (PCS); Range 0-52; higher scores indicate worse pain catastrophizing. |
| At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment) |
| Posttraumtic Stress Disorder (PTSD) Symptoms | PTSD Checklist for DSM-5 (PCL-5); Range 0-80; higher scores indicate worse PTSD symptoms. | At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment) |
| Kinesiophobia | Tampa Scale of Kinesiophobia (TSK); Range 17-68; higher scores indicate worse kinesiophobia. | At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment) |